Keywords: study, sheds, light, retrovir, dose, ongoing, debate

STUDY SHEDS LIGHT ON RETROVIR DOSE

Article | 13 January 1992

Print This

The ongoing debate over the recommended dosage of Wellcome's anti-AIDS drug Retrovir (zidovudine) has been clarified by a new study ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in